Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 99576
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.99576
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.99576
Table 1 Baseline data of two groups
| Data | Control group (n = 40) | Research group (n = 44) | χ2/t | P value |
| Age (years old) | 56.75 ± 7.28 | 55.75 ± 8.44 | 0.579 | 0.564 |
| Sex (male/female) | 24/16 | 23/21 | 0.508 | 0.476 |
| Diabetes duration (years) | 7.35 ± 2.13 | 6.68 ± 1.64 | 1.624 | 0.108 |
| Mean arterial pressure (mmHg) | 97.22 ± 11.40 | 99.84 ± 12.29 | 1.010 | 0.316 |
| Body mass index (kg/m2) | 22.32 ± 2.18 | 22.66 ± 3.58 | 0.519 | 0.605 |
| Heart rate (beats/min) | 78.45 ± 9.36 | 80.00 ± 7.33 | 0.849 | 0.398 |
- Citation: Li D, Qiao F, Dai J, Xu M, Gong HY, Yang HM, Li JC, Huai D. Therapeutic effectiveness of intratympanic and retroauricular methylprednisolone sodium succinate for refractory sudden sensorineural hearing loss in diabetic patients. World J Diabetes 2025; 16(5): 99576
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/99576.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.99576